IPSC:NASDAQ
Century Therapeutics Inc
$2.13
arrow_downward
-3.18%(-0.070) 1D
$2.10
arrow_downward
-1.41% (-0.030)bedtimeAfter hours
Closed: Jun 5, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IPSC...
Open
$2.17
High
$2.18
Low
$1.98
Mkt. cap
384.16M
Avg. vol.
788.55K
Volume
1.90M
52-wk high
$3.03
52-wk low
$0.44
EPS
-$1.11
Beta
1.56
Shares outstanding
180.36M
No. of employees
78
Open
$2.17
High
$2.18
Low
$1.98
Mkt. cap
384.16M
Avg. vol.
788.55K
Volume
1.90M
52-wk high
$3.03
52-wk low
$0.44
EPS
-$1.11
Beta
1.56
Shares outstanding
180.36M
No. of employees
78
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to IPSC in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for IPSC in the last 3 months.
Highest
Current $2.13
$8.00 (+275.59%)
Average
$5.90 (+177.00%)
Lowest
$4.00 (+87.79%)
News stories
From sources across the web
Yahoo Finance
·
2 hours ago
Here's How SpaceX's IPO Will Affect S&P 500 and Nasdaq-100 Investors
Simply Wall Street
·
52 minutes ago
Can PAPZIMEOS Durability Data Redefine Precigen’s (PGEN) Long-Term Revenue and Immunotherapy Narrative?
Investopedia
·
1 hour ago
Marvell Gets Another Shout-Out: It (And Flex) Are Joining the S&P 500
About Century Therapeutics Inc
CEO-
Employees78
Founded2018
HeadquartersPhiladelphia, Pennsylvania, United States
SectorBiotechnology
Websitecenturytx.com
AI content may include mistakes. Learn more